Miller JS - Search Results

1

iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy.

Cichocki F, Bjordahl R, Gaidarova S, Mahmood S, Abujarour R, Wang H, Tuininga K, Felices M, Davis ZB, Bendzick L, Clarke R, Stokely L, Rogers P, Ge M, Robinson M, Rezner B, Robbins DL, Lee TT, Kaufman DS, Blazar BR, Valamehr B, Miller JS. Cichocki F, et al. Among authors: miller js. Sci Transl Med. 2020 Nov 4;12(568):eaaz5618. doi: 10.1126/scitranslmed.aaz5618. Sci Transl Med. 2020. PMID: 33148626 Free PMC article.

2

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J Jr, Burns LJ. Miller JS, et al. Biol Blood Marrow Transplant. 1997 Apr;3(1):34-44. Biol Blood Marrow Transplant. 1997. PMID: 9209739 Clinical Trial.

3

Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.

Miller JS, Tessmer-Tuck J, Blake N, Lund J, Scott A, Blazar BR, Orchard PJ. Miller JS, et al. Exp Hematol. 1997 Oct;25(11):1140-8. Exp Hematol. 1997. PMID: 9328450

4

Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor.

Orchard PJ, Blazar BR, Burger S, Levine B, Basso L, Nelson DM, Gordon K, McIvor RS, Wagner JE, Miller JS. Orchard PJ, et al. Among authors: miller js. Hum Gene Ther. 2002 May 20;13(8):979-88. doi: 10.1089/10430340252939087. Hum Gene Ther. 2002. PMID: 12031130

5

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.

Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS, Velardi A, Blazar BR. Davies SM, et al. Among authors: miller js. Blood. 2002 Nov 15;100(10):3825-7. doi: 10.1182/blood-2002-04-1197. Epub 2002 Jul 5. Blood. 2002. PMID: 12393440 Free article.

6

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Barker JN, et al. Among authors: miller js. Blood. 2003 Sep 1;102(5):1915-9. doi: 10.1182/blood-2002-11-3337. Epub 2003 May 8. Blood. 2003. PMID: 12738676 Free article. Clinical Trial.

7

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS. Burns LJ, et al. Among authors: miller js. Bone Marrow Transplant. 2003 Jul;32(2):177-86. doi: 10.1038/sj.bmt.1704086. Bone Marrow Transplant. 2003. PMID: 12838283 Clinical Trial.

8

Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.

Chiorean EG, DeFor TE, Weisdorf DJ, Blazar BR, McGlave PB, Burns LJ, Brown C, Miller JS. Chiorean EG, et al. Among authors: miller js. Biol Blood Marrow Transplant. 2004 Mar;10(3):171-7. doi: 10.1016/j.bbmt.2003.10.004. Biol Blood Marrow Transplant. 2004. PMID: 14993882 Free article.

9

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.

Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, Verfaillie CM, Wagner JE. Barker JN, et al. Among authors: miller js. Blood. 2005 Feb 1;105(3):1343-7. doi: 10.1182/blood-2004-07-2717. Epub 2004 Oct 5. Blood. 2005. PMID: 15466923 Free article.

10

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.

Chen W, Chan AS, Dawson AJ, Liang X, Blazar BR, Miller JS. Chen W, et al. Among authors: miller js. Biol Blood Marrow Transplant. 2005 Jan;11(1):23-34. doi: 10.1016/j.bbmt.2004.08.004. Biol Blood Marrow Transplant. 2005. PMID: 15625541 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,124 results

Search Page